4993-93-5Relevant articles and documents
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
Paragraph 0399; 1746, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
Expedient synthesis of 1-hydroxy-4- and 1-hydroxy-6-nitroindoles
Bujok, Robert,Wrbel, Zbigniew,Wojciechowski, Krzysztof
, p. 1315 - 1320 (2012/07/13)
Reaction of -chloroalkyl ketones with 1,3-dinitrobenzenes provides 2,4-dinitrobenzyl ketones which when reduced with tin(II) chloride form 6-nitro derivatives of 1-hydroxyindoles. An alternative approach is the condensation of 2,4- and 2,6-dinitrotoluenes
Modulators of ATP-binding cassette transporters
-
Page/Page column 139, (2008/06/13)
Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.